Medical establishmentarians have come out of the woodwork to condemn the Trump administration's recent autism announcement. Although these health organizations dispute the administration's findings from a medical perspective, many of them omit their close ties to pharmaceutical companies.
President Donald Trump and Health Secretary Robert F. Kennedy Jr. sparked outrage among the medical establishment by formally naming acetaminophen, the active ingredient in Tylenol, as one of the alleged culprits behind the exponential increase of autism in American children.
Trump and Kennedy's announcement suggested that pregnant women who take acetaminophen could be at an increased risk of having children with neurological conditions like autism and ADHD. Kennedy also indicated that the U.S. Food and Drug Administration will notify physicians of the findings and that the Department of Health and Human Services will launch a nationwide campaign to inform parents of the potential risks.
